Profile
James J.
L'Italien held several senior positions in the pharmaceutical industry, including Vice President of Pharmaceutical Development at Amylin Pharmaceuticals and Senior VP of Regulatory Affairs & Quality Assurance at Somaxon Pharmaceuticals.
He also served as Chief Regulatory & Quality Officer at Novartis Gene Therapies.
L'Italien earned a doctorate from Boston University and an undergraduate degree from Merrimack College.
Former positions of James J. L'Italien
| Companies | Position | End |
|---|---|---|
Somaxon Pharmaceuticals, Inc.
Somaxon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceutical products | General Counsel | 23/04/2009 |
| LIGAND PHARMACEUTICALS INCORPORATED | General Counsel | 31/12/2006 |
Amylin Pharmaceuticals, Inc.
Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes medicines for diabetes, obesity and cardiovascular diseases | Corporate Officer/Principal | 31/12/1997 |
Ortho Biotech Products LP
Ortho Biotech Products LP Pharmaceuticals: MajorHealth Technology Provides innovative products and services to help enhance patients health | Chief Tech/Sci/R&D Officer | 31/12/1993 |
Smithkline Beecham Plc
Smithkline Beecham Plc Pharmaceuticals: OtherHealth Technology Develops and manufactures pharmaceutical products | Corporate Officer/Principal | 31/12/1990 |
Training of James J. L'Italien
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 10 |
|---|---|
Amylin Pharmaceuticals, Inc.
Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes medicines for diabetes, obesity and cardiovascular diseases | Health Technology |
Ligand Pharmaceuticals, Inc.
Ligand Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops and sells drug development technologies | Health Technology |
Smithkline Beecham Plc
Smithkline Beecham Plc Pharmaceuticals: OtherHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
InterMune, Inc.
InterMune, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that researches and develops therapies in pulmonology & orphan fibrotic diseases | Health Technology |
Somaxon Pharmaceuticals, Inc.
Somaxon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceutical products | Health Technology |
Boston University
Boston University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Merrimack College
Merrimack College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ortho Biotech Products LP
Ortho Biotech Products LP Pharmaceuticals: MajorHealth Technology Provides innovative products and services to help enhance patients health | Health Technology |
Baxter BioScience Corp.
Baxter BioScience Corp. BiotechnologyHealth Technology Provides biopharmaceutical and vaccines services | Health Technology |
Novartis Gene Therapies, Inc.
Novartis Gene Therapies, Inc. BiotechnologyHealth Technology Operates as a clinical-stage gene therapy company | Health Technology |
- Stock Market
- Insiders
- James J. L'Italien
















